Compare ITRM & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITRM | SPPL |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | Ireland | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 19.5M |
| IPO Year | 2018 | 2023 |
| Metric | ITRM | SPPL |
|---|---|---|
| Price | $0.47 | $4.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 2.5K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $390,000.00 | ★ $4,591,508.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $325.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.27 |
| 52 Week Low | $0.36 | $2.18 |
| 52 Week High | $3.02 | $16.80 |
| Indicator | ITRM | SPPL |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 50.45 |
| Support Level | $0.40 | $3.49 |
| Resistance Level | $0.50 | $4.75 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 58.91 | 71.56 |
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.